Regenerative medicine and advanced therapies are poised to transform healthcare. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options. Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing therapies.
Regenerative medicine and advanced therapies are large molecules, or biologics. The development, manufacturing, and administration of these types of therapies are often more complex than for traditional, small-molecule drugs.
Instead of treating the symptoms of a disease, these therapies treat the underlying cause by augmenting, repairing, replacing, or regenerating organs, tissues, cells, genes, and metabolic processes in the body.
Rather than repeat administration – such as a kidney patient requiring regular dialysis or a diabetic patient needing daily insulin – regenerative medicines may be effective with as little as one dose.
Because regenerative medicines address the root cause of disease, the benefits of these therapies last years, potentially for the entire lifetime of the patient.
Learn more about types of regenerative medicines ➔
